Hemostemix Launches $4M Financing for Stem Cell Therapy Growth

TipRanksOct 11 10:33 ET

Hemostemix Closed Private Placement

MT NewswiresOct 3, 2023 11:30 ET

Hemostemix Offers up to 500 6% Convertible Debentures, Convertible Into an ACP-01 Therapeutic Production Slot That Is Subject to Compassionate Exemption From Regulatory Approval

newsfileMar 7, 2023 09:07 ET

Hemostemix Inc. Is Maintained at Buy by Fundamental Research

Dow JonesAug 30, 2022 11:44 ET

Thomas Smeenk Sells 300,000 Shares of Hemostemix Inc. (CVE:HEM) Stock

ETF Daily NewsApr 24, 2022 12:15 ET

Hemostemix Appoints Chief Medical Officer

MT NewswiresOct 14, 2021 14:42 ET